Clinical Trials Logo

Clinical Trial Summary

To investigate whether an oral nutritional supplement of a mixture of arginine, glutamine and HMB for a maximum period of four weeks is more beneficial than the standard dietary approach to the healing of pressure ulcers, and to examine whether the use of it can reduce admissions and length of hospitalizations for these patients.


Clinical Trial Description

All patients would be assessed by a dietitian to ensure them receiving nutritional support of at least 30 kcal/kg/day and of at least 1.2 g/kg/day of protein regardless of feeding method. During the study period, vitamin C and zinc supplement would not be given. Nutritional supplement other than that provided by the dietitian to meet the energy and protein requirement would not be given. The pressure ulcers would be cared according to the "Basic nursing standards for patient care: Wound dressing - Version 5" published by the Hospital Authority Head Office.

The treatment group would also be given 2 Sackets of a mixture of arginine, glutamine and HMB (ABOUND) every day for a maximum period of 4 weeks, either orally or via enteral feeding. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03038490
Study type Interventional
Source Our Lady of Maryknoll Hospital
Contact Kwok Man Lo, FHKAM (Med)
Email lokm1@ha.org.hk
Status Recruiting
Phase N/A
Start date December 1, 2016
Completion date March 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT04311229 - Effectiveness of Negative-Pressure Wound Therapy N/A
Recruiting NCT05894291 - Comparaison of Two Prone Position Techniques on Occurence of Pressure Sores in ICU N/A
Completed NCT02222454 - Safety Evaluation of the KLOX BioPhotonic System in Stage II and III Pressure Ulcers N/A
Not yet recruiting NCT05649332 - Study to Evaluate the Performance and Safety of the Medical Device Argogen N/A
Completed NCT05130814 - EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers N/A
Recruiting NCT05496296 - Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries N/A
Completed NCT03283787 - Comparing Concomitant Use of ACell MicroMatrix® and ACell Cytalâ„¢ to Standard of Care in Stage 3 or 4 Pressure Injuries N/A